P210 Defining the minimal important difference for the visual analogue scale for dyspnoea in patients with malignant pleural effusions

P210 Defining the minimal important difference for the visual analogue scale for dyspnoea in patients with malignant pleural effusions

Détails bibliographiques
Auteurs principaux:	Mishra, E, Corcoran, J, Hallifax, R, Stradling, J, Maskell, N, Rahman, N
Format:	Journal article
Publié:	BMJ Publishing Group 2013

Documents similaires

Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
par: Mishra, E, et autres
Publié: (2015)

Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
par: Eleanor K Mishra, et autres
Publié: (2015-01-01)

THE USE OF INDWELLING PLEURAL CATHETERS FOR THE MANAGEMENT OF NON-MALIGNANT RECURRENT PLEURAL EFFUSIONS
par: Bhatnagar, R, et autres
Publié: (2012)

Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set
par: Mercer, RM, et autres
Publié: (2019)

Modern management of malignant pleural effusions
par: Mercer, R, et autres
Publié: (2016)

An unusual cause of progressive dyspnoea, pulmonary nodules and pleural effusions
par: Sudharsan Venkatesan, et autres
Publié: (2024-01-01)

Biological markers of successful pleurodesis for malignant pleural effusion
par: Psallidas, I, et autres
Publié: (2016)

Thoracic ultrasonography as a predictor of pleurodesis success in malignant pleural effusion
par: Corcoran, J, et autres
Publié: (2017)

Thoracic ultrasound as an early predictor of pleurodesis success in malignant pleural effusion
par: Corcoran, J, et autres
Publié: (2018)

Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion
par: Asciak, R, et autres
Publié: (2017)

Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion
par: Psallidas, I, et autres
Publié: (2016)

Assessment and treatment of malignant pleural effusions: visual analogue scale, ultrasound and drainage
par: Mishra, EK
Publié: (2013)

Malignant pleural effusion management: keeping the flood gates shut
par: Walker, S, et autres
Publié: (2019)

Survival and pleurodesis outcome in patients with malignant pleural effusion – post-hoc analysis from the TIME-1 trial
par: Hassan, M, et autres
Publié: (2018)

Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice.
par: Bhatnagar, R, et autres
Publié: (2014)

The palliation of malignant pleural effusions.
par: Bhatnagar, R, et autres
Publié: (2012)

Breathlessness post-drainage predicts survival in patients with malignant pleural effusion
par: Mishra, E, et autres
Publié: (2018)

ERS/EACTS statement on the management of malignant pleural effusions
par: Bibby, A, et autres
Publié: (2018)

Management of malignant pleural effusion
par: McCracken, D, et autres
Publié: (2018)

Randomised controlled trial of urokinase versus placebo for non-draining malignant pleural effusion
par: Mishra, E, et autres
Publié: (2018)

Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
par: Psallidas, I, et autres
Publié: (2018)

Ultrasound in predicting improvement in dyspnoea after therapeutic thoracentesis in patients with recurrent unilateral pleural effusion
par: Katrine Fjaellegaard, et autres
Publié: (2024-12-01)

Current best practice in the evaluation and management of malignant pleural effusions
par: Steven Walker, et autres
Publié: (2017-02-01)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
par: Ellayeh, M, et autres
Publié: (2021)

Objective thoracoscopic criteria in differentiation between benign and malignant pleural effusions
par: Ellayeh, M, et autres
Publié: (2021)

P234 Patient and fluid characteristics associated with non-draining malignant pleural effusion
par: Mishra, E, et autres
Publié: (2017)

Investigating suspected malignant pleural effusion.
par: Rahman, N, et autres
Publié: (2007)

Survival in patients with malignant pleural effusion undergoing talc pleurodesis
par: Hassan, M, et autres
Publié: (2019)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
par: Ellayeh, MA, et autres
Publié: (2021)

Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
par: Olfert, J, et autres
Publié: (2016)

ERS/EACTS statement on the management of malignant pleural effusions
par: Bibby, AC, et autres
Publié: (2018)

Malignant pleural mesothelioma with resolution of pleural effusion
par: Sayaka Nishida, et autres
Publié: (2023-11-01)

Derrame pleural neoplásico Malignant pleural effusion
par: Lisete Ribeiro Teixeira, et autres
Publié: (2006-08-01)

Biomarkers of malignancy in pleural effusions
par: José M. Porcel, et autres
Publié: (2024-10-01)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion.
par: Morel, A, et autres
Publié: (2011)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion
par: Morel, A, et autres
Publié: (2011)

Thoracic ultrasound in the diagnosis of malignant pleural effusion.
par: Qureshi, N, et autres
Publié: (2009)

Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
par: Maskell, N, et autres
Publié: (2003)

Chemotherapy does not increase the risk of pleural infection in patients managed with an indwelling pleural catheter for malignant pleural effusion
par: Morel, A, et autres
Publié: (2010)

Summary for clinicians: clinical practice guideline for management of malignant pleural effusions
par: Reddy, C, et autres
Publié: (2019)